You are here

Ron Renaud

Fresh from a $3.85B deal, biotech CEO sets sights on the next big thing

Fierce Biotech

Mon, 12/1/14 - 08:19 am

Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised

TheStreet.com

Tue, 01/28/14 - 11:17 am

Gilead Sciences